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Risk Factors at Index Hospitalization AssociatedWith Longer-term
Mortality in Adult Sepsis Survivors
Manu Shankar-Hari, MSc, PhD, FRCA, FFICM; David A. Harrison, PhD; Paloma Ferrando-Vivas, PhD; Gordon D. Rubenfeld, MD; Kathryn Rowan, MPhil
Abstract
IMPORTANCE Sepsis survivors, defined as adult patients who survived to hospital discharge
following a critical care unit admission for sepsis, are at increased risk of long-termmortality.
Identifying factors independently associated with long-termmortality, known during critical care
admission for sepsis, could inform targeted strategies to reduce this risk.
OBJECTIVE To assess, in adult sepsis survivors, factors independently associated with long-term
mortality, known during their index critical care admission for sepsis, meeting Third International
Consensus Definitions for Sepsis and Septic Shock criteria.
DESIGN, SETTING, AND PARTICIPANTS This cohort study included a nationally representative
sample of 94 748 adult sepsis survivors from 192 critical care units in England. Participants were
identified from consecutive critical care admissions between April 1, 2009, andMarch 31, 2014, with
survival status ascertained as of March 31, 2015. Statistical analyses were completed in June 2017.
EXPOSURES Generic patient characteristics (age, sex, ethnicity, severe comorbidities [defined using
the Acute Physiology and Chronic Health Evaluation II method], dependency, surgical status, and
acute illness severity [scored using the Acute Physiology and Chronic Health Evaluation II acute
physiology component]) and sepsis-specific patient characteristics (site of infection, number of
organ dysfunctions, and septic shock status) known during index critical care admission for sepsis.
MAINOUTCOMES ANDMEASURES Long-termmortality in adult sepsis survivors withmaximum
follow-up of 6 years. Adjusted hazard ratios (HRs) were estimated using Cox regression for both
generic and sepsis-specific patient characteristics.
RESULTS Sepsis survivors had amean (SD) age of 61.3 (17.0) years, 43 584 (46.0%) were female,
and 86056 (90.8%) were white. A total of 46.3% had respiratory site of infection. By 1 year from
hospital discharge, 15% of sepsis survivors had died, with 6% to 8% dying per year over the
subsequent 5 years. Age, sex, race/ethnicity, severe comorbidities, dependency, nonsurgical status,
and site of infection were independently associated with long-termmortality. Compared with single-
organ dysfunction, having 2 or 3 organ dysfunctionswas associatedwith increased risk of long-term
mortality (adjusted HR, 1.07; 95% CI, 1.01-1.13; and adjusted HR, 1.18; 95% CI, 1.03-1.14, respectively),
while having 4 organ dysfunctions or more was not associated with increased risk. Unexpectedly,
the Acute Physiology and Chronic Health Evaluation acute physiology component score had an
incremental association with long-termmortality (adjusted HR, 1.11 for every 5-point increase; 95%
CI, 1.08-1.13). The adjusted HR for septic shock was 0.89 (95% CI, 0.85-0.92).
(continued)
Key Points
Question Which generic and sepsis-
specific patient characteristics, known
during index critical care admission for
sepsis, are independently associated
with long-termmortality in sepsis
survivors?
Findings In this cohort study of 94 748
adult sepsis survivors, age, male sex, 1
or more severe comorbidities,
prehospitalization dependency,
nonsurgical status, acute severity of
illness, site of infection, and organ
dysfunction were independently
associated with long-termmortality.
Meaning Generic and sepsis-specific
risk factors, known during index critical
care admission for sepsis, could be used
to identify a higher-risk sepsis survivor
population for targeted strategies aimed
at reducing the excess risk of long-
termmortality.
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Abstract (continued)
CONCLUSIONS ANDRELEVANCE This study suggests that generic and sepsis-specific risk factors,
known during index critical care admission for sepsis, could identify a high-risk sepsis survivor
population for biological characterization and designing interventions to reduce long-termmortality.
JAMA Network Open. 2019;2(5):e194900. doi:10.1001/jamanetworkopen.2019.4900
Introduction
Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to
infection.1 Sepsis is common, with an estimated population incidence of 148 cases per 100000
person-years.2 Sepsis epidemiology studies from the past 2 decades consistently highlight both
increasing incidence and improving acute mortality.3,4 The result of this combination is an increasing
number of sepsis survivors (defined in this article as adult patients who survived to hospital discharge
following a critical care unit admission for sepsis). The ongoing health care needs of adult sepsis
survivors are an emerging global health care challenge.5
It is also well recognized that sepsis survivors have a greater risk of long-termmortality when
compared with patients hospitalized for nonsepsis reasons and the general population.6-9 A
systematic review6 that included 59 studies and explored the association between sepsis and long-
termmortality indicated that, on average, 16% of sepsis survivors die in the first year following their
index hospitalization for sepsis. There aremajor variations in the sepsis case definition and in the risk
factors assessed for this long-termmortality between studies. When studying risk factors for long-
termmortality in sepsis survivors, the factors associated with short-termmortality may overwhelm
and disguise factors associated with long-termmortality—as observed in many sepsis epidemiology
studies included in the recent systematic review.6,10 The reason for this is that an increase in sepsis
severity may worsen cumulative long-termmortality by increasing hospital mortality. This competing
risk of hospital mortality on long-termmortality may hide the impact of acute illness characteristics,
unless we study a sepsis survivor cohort. Therefore, the following should be considered in the
selection of factors to study: (1) potential factors associated with mortality should include both the
generic and sepsis-specific factors that resulted in the critical care admission for sepsis11; (2) generic
factors should relate to the baseline risk of death irrespective of sepsis (eg, severe comorbidity,
preadmission dependency status); and (3) sepsis-specific factors should reflect the severity of sepsis.
In this context, inferences are not biased when studying a sepsis survivor population (survivorship
bias), as the exposure of interest is conditional on surviving to hospital discharge following a critical
care admission for sepsis. If long-termmortality risk after sepsis is associated with acute illness
characteristics that are knownwhen a sepsis survivor leaves the hospital, those risk factors could be
used to identify a target sepsis survivor population for follow-up care, biological characterization,
and designing interventions.5,10
In this context, we assessed which of the generic (eg, age, sex) and sepsis-specific (eg, site of
infection, number of organ dysfunctions) patient characteristics, known during index critical care
admission for sepsis, were independently associated with long-termmortality in a sepsis survivor
population. To address our research aim, we identified a nationally representative cohort of sepsis
survivors from an inception cohort of adults with a critical care admission for sepsis according to the
Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)3 criteria who
survived to hospital discharge in England between April 1, 2009, andMarch 31, 2014.
Methods
StudyDatabase andApprovals
We report an observational cohort study, as per Strengthening the Reporting of Observational
Studies in Epidemiology (STROBE) guidelines.12 We used data from the Intensive Care National Audit
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&Research Centre (ICNARC) CaseMix Programme, which is the national clinical audit covering all adult
general critical care units in England. For consecutive critical care admissions, trained data collectors
collect sociodemographic, comorbidity, and physiological data to precise rules and definitions for the
patient’s first 24 hours following admission to critical care. Diagnostic data are determined clinically
and coded using a 5-tier, hierarchical ICNARC codingmethod (eAppendix in the Supplement).13
Collected data undergo extensive local and central validation prior to pooling into the Case Mix
ProgrammeDatabase.14 Patient-level unique identifiers are also generated for additional data linkage.13
Long-term survival status and date of death were ascertained by linking the CaseMix Programme
database to theHospital Episode Statistics database andOffice for National Statistics records.15 Support
for the collection and use of these data has been obtained under Section 251 of the National Health
Service Act 2006.Waiver of informed consent for use of this data was obtained fromWales Research
Ethics Committee 5 and Confidentiality Advisory Group, which approved this study as part of the
Long-termOutcomes After Critical Illness Project.
Identification of Sepsis Survivor Cohort
As of March 31, 2015, we ascertained the date of death for consecutive admissions to 192 adult,
general critical care units in England participating in the ICNARC CaseMix Programme between April
1, 2009, andMarch 31, 2014. From these, we identified a cohort of Sepsis-3 sepsis survivors, defined
as adult patients who survived to hospital discharge following an index critical care admission for
sepsis meeting Sepsis-3 criteria. We defined the index critical care admission for sepsis as the
hospitalization that included the first critical care unit admission with infection and total Sequential
Organ Failure Assessment score of 2 or greater. We defined septic shock as infection, with the
cardiovascular component of the Sequential Organ Failure Assessment of 2 or greater and a serum
lactate concentration greater than 18 mg/dL (to convert to millimoles per liter, multiply by 0.111), as
per Sepsis-3 criteria.1,16 We identified presence of infection from the reported primary (mandated)
and secondary (optional) reasons for critical care admission.3 As baseline organ dysfunction at index
critical care admissionwas unknown for our study cohort, we assumed a baseline organ dysfunction
of 0, as recommended by the Sepsis-3 consensus definitions.1 We have published this
operationalization,3 which included sensitivity analyses to confirm results by excluding patients with
any preexisting severe comorbidity (eTable 1 in the Supplement).
Statistical Analysis
The primary outcomewas time to death from any cause during follow-up. Generic and sepsis-specific
patient characteristics, known during index critical care admission for sepsis, were considered as risk
factors, informed by our systematic reviews.6,10 Generic patient characteristics includedwere sepsis
discharge year, age, sex, ethnicity, severe comorbidities (defined using the Acute Physiology and
Chronic Health Evaluation [APACHE II] method17), prehospitalization dependency, surgical status,
and acute severity of illness defined using the APACHE II acute physiology component score.17 The
prehospitalization dependency is a subjective assessment of whether the participant receives no,
some, or total assistance to complete daily activities such as bathing, dressing, going to the toilet,
moving in and out of a bed or chair, continence, and eating prior to critical care admission. Sepsis-
specific patient characteristics included were site of infection, number of organ dysfunctions defined
as Sequential Organ Failure Assessment score of 1 or greater per organ, and septic shock status.
First, we generated cumulative time-to-mortality plots for all generic and sepsis-specific patient
characteristics and tested equality of mortality functions using a Peto-Peto-Prentice log-rank test.
The Peto-Peto-Prentice log-rank test was specifically chosen because it is not affected by differences
in censoring patterns across different strata. We then assessed which generic and sepsis-specific
patient characteristics were independently associated with long-termmortality in adult sepsis
survivors using adjusted hazard ratios (HRs) from proportional hazards (Cox) regression modeling.
The categorical variables were sex, race/ethnicity, severe comorbidity, surgical status, preadmission
dependency, site of infection, number of organ dysfunctions, and septic shock status. Continuous
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variables were entry date (index date of discharge from hospital), age (in decades), APACHE II acute
physiology component score (in 5-point increments), and index hospital length of stay. A priori, we
included an interaction term between the APACHE II acute physiology component score (in 5-point
increments) and severe comorbidities. We also estimated time-varying coefficients for age (in
decades), APACHE II acute physiology component score (in 5-point increments), and severe
comorbidities using an interaction between the covariate and follow-up time that allowed the
strength of association between a risk factor and the event of interest to either increase or decrease
during the course of follow-up. For all Cox regression models, we tested for evidence against the
proportional hazard assumption on the basis of Schoenfeld residuals after fitting a model with Cox
regression.18 We gave equal weights to different comorbidities for interpretability, accounted for
clustering by intensive care units using robust standard errors, did not perform any variable selection
approaches, and used the Breslowmethod for handling ties, which considers each event at a given
time as distinct and allows all failed subjects to contribute fully to the risk set (here, failed subjects is a
technical term referring to how the Breslowmethod handles ties within the Coxmodel).
Sensitivity Analyses
We performed 5 separate sensitivity analyses. First, to account for overlap in variables that
contribute toward the APACHE II acute physiology component score and severe comorbidity (eg,
creatinine, oxygenation), we performed a sensitivity analysis replicating the Cox regressionmodel in
patients without severe comorbidity. Second, to ascertain whether changes observed were
influenced by coverage (additional critical care units participating in the Case Mix Programme over
time), we repeated all the analyses on a subpopulation of 117 critical care units that contributed data
to the Case Mix Programme for the entire study period. Third, to ascertain whether the primary
analyses hold true, as in a 5-year cohort study the adjusted HR could change, we report the adjusted
HR overlapping time intervals 0 to 1, 0 to 2, 0 to 3, 0 to 4, and 0 to 5 years following hospital
discharge. Fourth, to ascertain whether changes observed were influenced by an unobserved
random factor between critical care units that modifies the hazard function of an individual or a
group or cluster of individuals, we report a mixed-effects Coxmodel (shared frailty model).19 Fifth, to
provide direct comparison with recently published cohort studies,7-9 we estimated the excess long-
termmortality in sepsis survivors compared with age-, sex-, and index year–matched expected
probabilities of death20 in the general population of England between 2009 and 201421 using the
relative survival framework with Ederer II estimation.
Reported P values are 2-sided, with P values less than .05 considered to represent statistically
significant results. Continuous data that were normally distributed were summarized as mean and
standard deviation. Data that were not normally distributed were summarized as median and
interquartile range (IQR). Categorical data were presented as frequency and percentage. Data
completeness was extremely good; therefore, a complete case analysis was used, with less than
0.5% of patients excluded from the final model owing tomissing data on risk factors. Statistical
analyses were completed in June 2017. All analyses were performed using Stata/SE statistical
software version 14.0 (StataCorp LP).
Results
Study Cohort
Over the 5-year study period (April 1, 2009, to March 31, 2014), there were 152 383 index critical care
admissions for sepsis and 98 732 sepsis survivors. After exclusions for age younger than 16 years
(976 patients) and those sepsis survivors who were discharged from the hospital after March 31,
2014 (3008 patients), the sepsis survivor study cohort included 94 748 patients (Figure 1; eFigure
in the Supplement).
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Cohort Characteristics and Long-termMortality
Overall, these sepsis survivors had amean (SD) age of 61.3 (17.0) years, 43 584 (46.0%) were female,
and 86056 (90.8%) were white. Sepsis survivors more often had nonsurgical admissions (69.3%).
The most common site of infection was respiratory (46.3%), the critical care admission day mean
(SD) total APACHE II score was 16.7 (5.9) points, and themedian (IQR) critical care length of stay was
4 (2-8) days. Further generic and sepsis-specific patient characteristics are reported in the Table. By
1 year after hospital discharge, 15% of sepsis survivors had died, with 6% to 8% dying per year over
the next 5 years (Figure 2). Cumulative time-to-mortality plots indicated significant within-strata
differences (Figure 3).
Factors Independently AssociatedWith Long-termMortality
Among the generic patient characteristics assessed, increasing age, beingmale, having 1 or more
severe comorbidities, having some or total dependency prior to index critical care admission, and
longer index hospital length of stay increased the risk of long-termmortality in sepsis survivors,
consistent with published literature. Compared with sepsis survivors who survived their index critical
care admission for sepsis between April 2009 andMarch 2010, sepsis survivors in later years had
higher risk of long-termmortality (adjusted HR, 1.02; 95% CI, 1.01-1.03, equating to 2% increase in
hazard per year; P < .001). Increasing score on the APACHE II acute physiology component was
significantly associatedwith increased risk of long-termmortality (adjustedHR, 1.11 for every 5 points;
95%CI, 1.08-1.13; P < .001). Patients with surgical status had a lower risk of long-termmortality than
those with nonsurgical (medical) status (Figure 4; eTable 2 in the Supplement).
Among the sepsis-specific characteristics assessed, when compared with respiratory site of
infection, gastrointestinal, genitourinary, musculoskeletal, and neurological sites of infection had
adjusted HRs for long-termmortality less than 1. Compared with single organ dysfunction, having
either 2 or 3 organ dysfunctions was associated with greater mortality (adjusted HR, 1.07; 95% CI,
Figure 1. FlowDiagram for Identification of Sepsis Survivor Cohort
482 861 Patients from 565 019 total critical care admissions
in England from April 1, 2009, to March 31, 2014
468 179 Patients with 541 575 critical care admissions with
linked data
152 383 Patients with 167 860 critical care admissions with
sepsis
98 732 Sepsis survivors
94 748 Sepsis survivors with minimum follow-up of 1 y
14 682 Patients with 2344 admissions excluded (outcome
data linkage not achieved)
336 631 Patients with 373 715 admissions
(admissions without sepsis)
12 885 Patients with 15 477 admissions excluded
(second or subsequent admission to critical care)
3984 Excluded
976 Age <16 y
3008 Discharged from hospital after March 31, 2014
53 651 Excluded
52 732 Died in hospital
919 Missing hospital outcome
152 383 Patients with 152 383 index sepsis admissions
Sepsis survivors were defined as adult patients who
survived to hospital discharge following an index
critical care admission with sepsis. We defined the
index critical care admission for sepsis as the
hospitalization in the study period that included the
first critical care unit admission for sepsis as defined by
the Third International Consensus Definitions for
Sepsis and Septic Shock.1,3 Thus, each sepsis survivor
was included only once in the study, based on his or
her index critical care admission for sepsis. Some
patients have 1 or more critical care admissions with
and without sepsis during the study period. Patients
with nonsepsis admission may be readmitted during
the study period for their index (first) critical care
admission for sepsis.
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Table. Characteristics of Sepsis Survivor Cohorta
Parameter No. (%)
Critical care units contributing to data, No. 192
Index sepsis admissions, No.b 152 383
In-hospital mortalityc 52 732 (34.6)
Sepsis survivors with minimum follow-up time of 1 y following hospital dischargeb 94 748 (100)
Sepsis survivors whose discharge disposition was normal residence 83 378 (88.0)
Age, mean (SD), y 61.3 (17.0)
Female 43 584 (46.0)
Race/ethnicity
White 86 056 (90.8)
Asian 3378 (3.6)
Black 2020 (2.1)
Otherd 3924 (3.5)
Severe comorbiditye
0 80 461 (84.9)
1 11 097 (11.7)
≥2 3190 (3.4)
Preadmission dependency
No dependency 70 737 (75.0)
Some dependency 22 427 (23.8)
Totally dependent 1187 (1.3)
Admission type
Nonsurgical (medical) 65 691 (69.3)
Elective surgical 5526 (5.8)
Emergency surgical 23 522 (24.8)
Total Acute Physiology and Chronic Health Evaluation II score, mean (SD) 16.7 (5.9)
Acute Physiology and Chronic Health Evaluation II acute physiology component score,
mean (SD)
12.4 (5.2)
Site of infection
Respiratory 43 858 (46.3)
Gastrointestinal 28 630 (30.2)
Cardiovascular 1612 (1.7)
Genitourinary 6747 (7.1)
Musculoskeletal, dermatological, or hematological 5075 (5.4)
Neurological 3206 (3.4)
Unknown 5620 (5.9)
Organ dysfunction, No.f
1 9727 (10.3)
2 26 878 (28.4)
3 31 119 (32.8)
4 21 075 (22.2)
≥5 5949 (6.3)
Septic shock 13 276 (14.0)
Length of stay, median (IQR), d
Critical care 4 (2-8)
Hospital 21 (11-40)
Follow-up, median (IQR) [maximum], d 893 (499-1409) [2172]
Mortality during follow-up, No./No. (%)g
0-1 y 13 819/94 748 (14.6)
1-2 y 5163/62 358 (8.3)
2-3 y 3057/41 000 (7.5)
3-4 y 1628/23 893 (6.8)
4-5 y 662/9722 (6.8)
Abbreviation: IQR, interquartile range.
a As defined by the Third International Consensus
Definitions for Sepsis and Septic Shock criteria.
b Figure 1 shows exclusions (976 patients aged <16
years; 3008 patients with hospital discharge after
March 31, 2014).
c eFigure 2 in the Supplement shows the proportion of in-
hospital deaths.
d Other includes mixed race/ethnicity or not stated.
e Comorbidities using Acute Physiology and Chronic
Health Evaluation II method.17
f As defined by Sequential Organ Failure
Assessment score.
g The denominator indicates patients who survived
the previous interval, then either died or survived
but had the full follow-up for that interval, resulting
in 18 571 patients between 1 to 2 years; 16 195
between 2 to 3 years; 14 050 between 3 to 4 years;
and 12 543 between 4 to 5 years excluded from the
denominator.
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1.01-1.13; and adjusted HR, 1.18; 95% CI, 1.03-1.14, respectively), while having 4 or more organ
dysfunctions was not. Septic shock at index admission had an adjusted HR of 0.89 (95% CI,
0.85-0.92; P < .001) for long-termmortality in sepsis survivors (Figure 4; eTable 2 in the
Supplement).
Factors ThatModify the Association of Acute Severity of Illness
With Long-termMortality
The association of APACHE II acute physiology component score on longer-termmortality decreased
by 4% per year for sepsis survivors with 1 comorbidity and 7% per year for those with 2 or more
severe comorbidities. We observed a 4% increase in time-varying hazard per year for age. The time-
varying reduction in the hazard for the APACHE II acute physiology component score was less than
2% per year, compared with the 9% decrease in hazard per year for 1 severe comorbidity and 20%
decrease in hazard per year for 2 or more severe comorbidities, implying patients with more
comorbidities died earlier during follow-up (Figure 4; eTable 2 in the Supplement).
Sensitivity Analyses
Results from sensitivity analyses were consistent with the primary analyses for the generic and
sepsis-specific risk factors assessed. For example, all sensitivity analyses had similar adjusted HRs for
increments in the APACHE II acute physiology component score (1) in sepsis survivors without severe
comorbidities (n = 80 139; adjustedHR, 1.11 for every 5 points; 95%CI, 1.08-1.13), (2) from 117 critical
care units that contributed data over the entire study period (n = 68 703; adjusted HR, 1.10 for every
5 points; 95% CI, 1.07-1.13), (3) for overlapping survival-time intervals, and (4) for random variation
with shared frailty model (adjusted HR, 1.08 for every 5 points; 95% CI, 1.07-1.10) (eTable 2 in the
Supplement). The relative survival analysis was comparable to previous reports, with survival
decreasing from 87.3% by 1 year to 69.2% by 5 years (eTable 3 in the Supplement).
Discussion
In this cohort of adult sepsis survivors, as defined by Sepsis-3 criteria, both generic and sepsis-
specific patient characteristics known during the index critical care admission for sepsis were
independently associated with long-termmortality. Increasing age, male sex, 1 or more severe
comorbidities, prehospitalization dependency, and nonsurgical (medical) status increased the risk of
long-termmortality. The risk of long-termmortality differed by site of infection at index critical care
admission for sepsis. Novel findings were the incremental increase in risk of long-term death in sepsis
survivors associatedwith increased APACHE II acute physiology component score (adjusted HR, 1.11;
Figure 2. Cumulative All-Cause Long-termMortality in Adult Sepsis Survivors Compared
With Age- and Sex-Matched General Population
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95% CI, 1.08-1.13 for every 5 points), lower risk associated with septic shock (adjusted HR, 0.89; 95%
CI, 0.85-0.92), and the variation in additional hazard for long-term death associated with number of
organ dysfunctions. The greater number of in-hospital deaths in patients with septic shock and in
patients with greater organ dysfunction is themost likely explanation for these results,3,11 an
important finding that is often overlooked when estimated using cumulative mortality.
Oneof the key reasonswhywe studied a sepsis survivor populationwas to unmask the important
risk factors associatedwith long-termmortality,which are oftendisguisedby the risk factors associated
with short-termmortality, such as acute illness severity. The incremental increase in hazard seenwith
increasingAPACHE II acute physiology component score persisted in the sensitivity analysis, excluding
patientswith chronic severe comorbidity. This finding,when considered in the context of clinical11 and
biological22 differenceswithin sepsis cohorts, reinforces the value of how routinely available clinical
information on index critical care admission for sepsis could inform follow-up care of sepsis survivors.
This reasoning is strengthenedwhennoting the differences in the impact of site of infection on long-
termmortalityweobserved, as site of infection potentially influences immune responses.23 A related
Figure 3. Cumulative All-Cause Long-termMortality by Risk Factors in Adult Sepsis Survivors
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Third International Consensus Definitions for Sepsis and Septic Shock) over follow-up
within generic characteristics (age,1 severe comorbidities, and Acute Physiology and
Chronic Health Evaluation II (APACHE II) acute physiology score quartile strata) and
sepsis-specific characteristics (site of infection; number of organ dysfunction; and septic
shock status) (all P < .001 using Peto log-rank test). Number of patients at risk is shown
in eTable 4 in the Supplement.
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Figure 4. Adjusted Hazard Ratios (HRs) for Each Risk Factor on Long-termMortality by Survival Time
in Adult Sepsis Survivors
P ValueFavors
Decreased Risk
Favors
Increased Risk
1010.1
Adjusted HR (95% CI)
Risk Factor
Entry date (per y) .003
Age (per 10 y) <.001
Male (vs female)
<.001
<.001
<.001
<.001
<.001
<.001
<.001
<.001
<.001
<.001
.009
<.001
.005
<.001
Race/Ethnicity
White
Patients,
No.
94 231
94 231
50 867
85 590
3363
2007
3271
79 967
70 650
22 402
65 331
23 392
94 231
94 231
5508
1179
11 077
3187
Asian
Other
Black
Severe comorbidity
0
1
≥2
No
Preadmission dependency
Some dependency
Fully dependent
Admission type
Elective surgical
Nonsurgical (medical)
Emergency surgical
APS-APII (per 5 points)
Hospital LOS (per 7 d)
Interactions
1
Severe comorbidity x APS-APII
Time varying coefficients
≥2
Age (per 10 y)
1
Severe comorbidity
≥2
APS-APII (per 5 points)
Adjusted HR
(95% CI)
1.33 (1.31-1.35)
1.19 (1.16-1.22)
1.02 (1.01-1.03)
1.00
1.00
1.00
1.00
0.80 (0.74-0.87)
2.42 (2.18-2.70)
4.83 (4.03-5.79)
1.45 (1.40-1.51)
2.32 (2.03-2.66)
0.78 (0.73-0.83)
0.87 (0.84-0.91)
1.10 (1.08-1.13)
1.02 (1.02-1.03)
0.96 (0.93-0.99)
0.93 (0.89-0.98)
1.04 (1.04-1.05)
0.91 (0.89-0.94)
0.80 (0.76-0.85)
0.98 (0.97-0.99)
0.91 (0.81-1.01)
0.91 (0.84-0.99)
Generic characteristicsA
P ValueFavors
Decreased Risk
Favors
Increased Risk
1010.1
Adjusted HR (95% CI)
Risk Factor
Site of infection
Respiratory
Cardiovascular
Gastrointestinal
Genitourinary
Patients,
No.
1600
43 615
28 487
6717
5046
3170
5596
9683
26 738
30 937
20 948
5925
13 180
Musculoskeletal
Unknown
Neurological
Organ dysfunction
1
2
3
4
≥5
Septic shock
Adjusted HR
(95% CI)
1.02 (0.92-1.12)
1.07 (1.01-1.13)
1.09 (1.03-1.14)
1.06 (1.00-1.12)
1.01 (0.94-1.09)
0.89 (0.85-0.92)
1.00
1.00
0.81 (0.78-0.84)
0.91 (0.87-0.96)
0.82 (0.77-0.87)
0.60 (0.54-0.68)
0.99 (0.94-1.05)
Sepsis-specific characteristicsB
Adjusted HRs generated using the primary Cox
regressionmodel (eTable 2 in the Supplement) are
shown for generic risk factors, time-varying
coefficients (for age in decades, acute physiology
component of Acute Physiology and Chronic Health
Evaluation II [APACHE II] score per 5-point increments,
and severe comorbidity) and interactions (A) and
sepsis-specific risk factors (B). The P values represent
test for homogeneity within groups, estimated using a
postestimation command to look for significant
differences after the Cox regressionmodel. See the
Methods section for the base category for each risk
factor. Sepsis was defined according to the criteria of
the Third International Consensus Definitions for
Sepsis and Septic Shock. APII-APS indicates acute
physiology component of APACHE II; and LOS, length
of stay.
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argument in this context is that even in 2 patientswith similar predicted risk butwith differences in rela-
tive contributions of generic and sepsis-specific risk components, differenceswould exist in treatability
of long-term sequalae. Thus,when these factors independently associatedwith long-termmortality
fromour results are consideredwith those from the literature,5,6,8,10,24,25 it indicates that sepsis survi-
vors both retain risk from index critical care admission for sepsis but also accumulate additional risk
following hospital discharge from theirworsening preexisting comorbidities26 and/or newcomorbidi-
ties (eg,worsening cognition,24 cardiovascularmorbidity27), both ofwhich are associatedwith in-
creased risk of long-termmortality. Thus, our studymakes a case for understanding howmanagement
followingdischarge could alter sepsis survivors’ risk of long-termadverse outcomes.26
Strengths
We used the CaseMix Programme database, which is a national database for critical care units in
England and has been independently assessed to be of high quality.14 We reduced selection bias by
studying consecutive critical care admissions for sepsis from 192 critical care units representing the
whole critical care population in a country over a 6-year period and commencing patient follow-up
from hospital discharge with 96% data linkage for long-termmortality. Long-termmortality from a
single health care system is often challenged on external validity owing to differences in clinical
care.28 We havemaximized the external validity of our study by using a valid Sepsis-3 sepsis case
definition in a nationally representative adult sepsis survivor cohort older than 16 years. These are
important strengths, as, of the 2 recent long-term sepsis outcome studies, 1 focused on older adults
(65 years) with insurance coverage admitted between 2002 and 2010,8 and the second reported
sepsis cases between 2000 and 2002 from a national health insurance database.7
Limitations
This study has limitations. As seen in all follow-up studies, our cohort had different durations of
follow-up. We used proportional hazards modeling to account for differences in follow-up duration
and adjusted for common confounders6,10 in the association between sepsis and long-termmortality
based on systematic review of literature.6 Our study cohort reports the epidemiology of adult sepsis
survivors, who all had critical care admissions with sepsis identified in the first 24 hours of admission.
Thus, wewill underestimate patients with nonsepsis critical care admissionswho develop sepsis later
in their critical care stay. However, as England has among the lowest per capita critical care bed
provision in Europe (3.5-7.4 per 100000 population),29 probability of underestimation is low, as
organ dysfunction will often be present on admission day. Wewere not able to study the biological
mechanisms that could explain our findings. Information bias due to misclassification of sepsis
exposure or long-termmortality is a risk that we reduced by deriving sepsis cases using raw
physiology and long-termmortality from a high-quality national data source. As our goal was to
identify risk factors, we have only reported age- and sex- matched general population controls for
comparison with those studies that quantify excess long-term risk of death from sepsis.7-9 Amarker
of physiological disturbance closer to discharge would be potentially useful, with the counterpoints
that the median critical care length of stay was 4 days and if there was significant physiological
disturbance, patients would not be discharged from the hospital. We do not present a risk score to
implement at bedside, as this was not our research question. Although we did not estimate a formal
sample size calculation, we do report the long-termmortality from the largest adult sepsis survivor
cohort to date.
Our observations that acute illness severity and site of infection at index admission are
associated with increased risk of long-termmortality in sepsis survivors has biological plausibility and
informs future research. Acute illness severity and illness trajectory seenwith critical care admissions
for sepsis are associatedwith health before the illness causing hospitalization, immune responses in
sepsis,22,30,31 and early appropriate clinical management.32-34 Immune abnormalities seen in patients
with sepsis31 appear to persist in sepsis survivors.35,36 New or relapsed infection is one of the
common reasons for rehospitalization in sepsis survivors, which is potentially associated with site of
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infection at index sepsis admission.10,37 Thus, observational studies identifying biological
characteristics and value of parsimonious clinical prediction tools using generic and sepsis-specific
risk factors to predict risk of long-term adverse health in sepsis survivors would be valuable. The
future interventional trials may include clinical practice interventions such as extended follow-up
care either by primary care physicians5 or with targeted follow-up clinics38 or immunological
interventions informed by acute sepsis illness biology.31,39,40 Our study adds further impetus to the
recently adopted World Health Organization resolution calling for further work informing “policy
decisions related to preventive, diagnostic and treatment activities and access to relevant health care
for sepsis survivors.”41
Conclusions
Generic and sepsis-specific risk factors, known during index critical care admission for sepsis, are
important risk factors associated with long-termmortality seen in a sepsis survivor cohort. Our
research provides validity to target sepsis survivor populations based on index admission
characteristics, for biological characterization and designing interventions to reduce long-term
mortality.
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